Proactive Care Coordination for Cancer Survivors Who Smoke
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/13/2018 |
Start Date: | March 2016 |
End Date: | September 29, 2018 |
Using Cancer Registry Data to Promote Proactive Tobacco Cessation Among Adult Cancer Survivors U48
This is a population-based randomized controlled trial of 600 patients with a diagnosis of
cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that
will inform critical questions regarding the relative efficacy of care coordination options,
the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will
react to proactive tobacco related communications. Investigators will compare the reach and
efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm
1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm
randomized design at two urban cancer centers, and will explore cancer survivor attitudes and
preferences about proactive tobacco treatment.
cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that
will inform critical questions regarding the relative efficacy of care coordination options,
the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will
react to proactive tobacco related communications. Investigators will compare the reach and
efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm
1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm
randomized design at two urban cancer centers, and will explore cancer survivor attitudes and
preferences about proactive tobacco treatment.
Inclusion Criteria:
- ICD 9 cancer diagnosis seen at each site in the past two years
- Documentation of current smoking in the cancer registry.
Exclusion Criteria:
- Dementia
- Stage IV or Stage IIIB cancer
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Paul Krebs, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials